Literature DB >> 8055216

Hypercomplementaemia as a marker of the evolution from benign to malignant B cell proliferation in patients with type II mixed cryoglobulinaemia.

C Vitali, C Ferri, P Nasti, L La Civita, M Mazzantini, G Longombardo, S Bombardieri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8055216     DOI： 10.1093/rheumatology/33.8.791

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN： 0263-7103


× No keyword cloud information.
  6 in total

1.  Extreme hypercomplementemia in the setting of mixed cryoglobulinemia.

Authors:  Bharath Manu Akkara Veetil; Thomas G Osborn; Dean F Mayer
Journal:  Clin Rheumatol       Date:  2011-01-07       Impact factor: 2.980

Review 2.  Infectious serologies and autoantibodies in hepatitis C and autoimmune disease-associated mixed cryoglobulinemia.

Authors:  Merav Lidar; Noga Lipschitz; Nancy Agmon-Levin; Pnina Langevitz; Ori Barzilai; Maya Ram; Bat-Sheba Porat-Katz; Nicola Bizzaro; Jan Damoiseaux; Jan Willem Cohen Tervaert; Salvatore deVita; Stefano Bombardieri; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

Review 3.  Cryoglobulins.

Authors:  C Ferri; A L Zignego; S A Pileri
Journal:  J Clin Pathol       Date:  2002-01       Impact factor: 3.411

Review 4.  Mixed cryoglobulinemia.

Authors:  Clodoveo Ferri
Journal:  Orphanet J Rare Dis       Date:  2008-09-16       Impact factor: 4.123

Review 5.  Hepatitis C virus and autoimmunity.

Authors:  Barbara C Böckle; Norbert T Sepp
Journal:  Auto Immun Highlights       Date:  2010-07-10

Review 6.  Vasculitides and the Complement System: a Comprehensive Review.

Authors:  Maria Sole Chimenti; Eleonora Ballanti; Paola Triggianese; Roberto Perricone
Journal:  Clin Rev Allergy Immunol       Date:  2015-12       Impact factor: 10.817
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.